• NU6300 Targets Gasdermin D at Cysteine-191

  2026-08-12

  Jiang et al. identify NU6300 as a covalent gasdermin D inhibitor that targets cysteine-191 and blocks both gasdermin D cleavage and palmitoylation. The study links this mechanism to impaired membrane localization, oligomerization, and pyroptosis, while showing protective effects in experimental colitis and sepsis models.

• JNJ-10198409: PDGF Receptor Inhibition Workflows

  2026-08-12

  JNJ-10198409 provides a nanomolar starting point for dissecting PDGF-BB-driven kinase signaling, proliferation, migration, and angiogenesis-related phenotypes. This practical guide translates its ATP-site mechanism into dose-response, pathway-engagement, and troubleshooting workflows for cancer biology and fibrotic disorder research.

• PR-619: Deubiquitylating Enzymes Inhibitor Guide

  2026-08-11

  PR-619 is a reversible, cell-permeable DUB inhibitor for separating ubiquitination changes from direct proteasome blockade. This guide covers practical dosing, autophagy and cancer workflows, neurodegeneration applications, and troubleshooting for more interpretable cell-based assays.

• Olive Oil Polyphenols in Cardiovascular Protection

  2026-08-10

  Boumezough et al. compare standard and naturally high-phenolic extra virgin olive oil extracts with hydroxytyrosol and tyrosol to connect polyphenol concentration with antioxidant, anti-inflammatory, and cholesterol-efflux effects. The findings provide a useful cellular framework for studying oxidative stress modulation and atheroprotective mechanisms, while also emphasizing the limits of extrapolating in vitro activity to clinical cardiovascular benefit.

• KNUCKLES Controls Floral Meristem Termination

  2026-08-09

  This Arabidopsis study identifies KNUCKLES as an epigenetic coordinator of floral meristem termination, linking repression of WUS and CLV3 with direct control of PIN1 and IPT7. The findings establish how auxin distribution and cytokinin activity are jointly adjusted to convert a transient floral meristem into a determinate structure.

• RapaLink-1: A Resistance-Aware mTOR Framework

  2026-08-08

  RapaLink-1 is a third-generation mTOR inhibitor that combines mutation-aware potency with a disciplined framework for interpreting oncology and dormancy assays. This article connects bivalent mTORC1 inhibition to pathway readouts, protocol selection, and the limits of translating developmental models into cancer research.

• Streptavidin-HyperFluor 647 Workflow Guide

  2026-08-07

  Streptavidin-HyperFluor 647 provides red/far-red detection for biotinylated antibodies, nucleic acids, proteins, and imaging targets across microscopy and flow cytometry. This guide shows how to use it alongside, rather than confuse it with, the biotin-free BmTyr proximity-labeling strategy reported in primary T cells.

• Reversing Cancer Drug Resistance: Strategic Insights with Zo

  2026-08-07

  Explore how Zosuquidar (LY335979) 3HCl, a selective P-gp inhibitor from APExBIO, is transforming the translational research landscape by overcoming multidrug resistance in cancer. This thought-leadership article bridges mechanistic understanding, protocol guidance, and actionable strategy for researchers seeking to enhance chemotherapeutic efficacy and address clinical challenges.

• EZ Cap™ Cre mRNA (m1Ψ): Precision Gene Editing in Extrahepat

  2026-08-06

  EZ Cap™ Cre mRNA (m1Ψ) enables high-efficiency, low-immunogenicity Cre/loxP recombination in tissues beyond the liver, thanks to advanced stability modifications and innovative delivery strategies. This guide details optimized workflows, troubleshooting, and the impact of virus-mimicking delivery systems for robust extrahepatic gene editing.

• Neurotensin in Translational Research: Mechanisms and Strate

  2026-08-06

  Explore how Neurotensin (CAS 39379-15-2) empowers advanced GPCR trafficking and microRNA regulation studies, with practical guidance for translational scientists navigating mechanistic complexity, experimental pitfalls, and clinical potential.

• Pterostilbene Enhances Mitochondrial Quality to Delay Fibrob

  2026-08-05

  Zhou et al. reveal that pterostilbene delays senescence in human dermal fibroblasts by improving mitochondrial quality, particularly through enhanced mitophagy. These findings offer mechanistic insight into skin aging and suggest new avenues for intervention targeting fibroblast function.

• ERAD-Hijacking Chimeras Enable Degradation of TM Proteins

  2026-08-05

  Song et al. introduce ERAD-engaging chimeras (ERADECs), a small-molecule-based platform that selectively degrades transmembrane proteins by harnessing the ER-associated degradation (ERAD) pathway. This innovation addresses a major limitation of current targeted protein degradation techniques and demonstrates substantial efficacy in degrading membrane targets such as PD-L1, providing new avenues for therapeutic and mechanistic research.

• Cyclic di-GMP: Applied Workflows for Biofilm & Immune Resear

  2026-08-04

  Cyclic di-GMP is transforming both biofilm regulation and immune modulation research, powering precision workflows from chronic infection models to cancer immunotherapy studies. This guide translates the latest mechanistic findings into actionable experimental protocols and troubleshooting strategies, revealing how APExBIO's high-purity cyclic di-GMP supports next-generation research across domains.

• PCI-32765 (Ibrutinib) Workflows for B-Cell and Glioma Resear

  2026-08-04

  PCI-32765 (Ibrutinib) empowers researchers to dissect B-cell receptor signaling and model resistance in both hematological and ATRX-deficient glioma settings. This guide delivers actionable protocols, troubleshooting insights, and translational context for maximizing experimental success with this irreversible BTK inhibitor.

• FAK Inhibitor 14 in Cancer Biology: Workflows & Troubleshoot

  2026-08-03

  FAK Inhibitor 14 (benzene-1,2,4,5-tetraamine tetrahydrochloride) empowers researchers to dissect FAK-mediated tumorigenic signaling and EMT in advanced models of ovarian cancer. This guide details optimized protocols, troubleshooting strategies, and practical insights for leveraging this APExBIO compound in studies of cell migration inhibition and tumor metastasis.

448 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page